Dibekacin assay in serum by automated fluorescence polarization immunoassay (Abbott Tdx): Comparison with high-performance liquid chromatography, substrate-labelled fluorescent immunoassay and radioimmunoassay.

Rollmann, Bruno;Van Der Auwera, P;Tulkens, Paul M.
(1986) Journal of Pharmaceutical and Biomedical Analysis — Vol. 4, n° 1, p. 53-61 (1986)

Files

No attached file found for this publication.

Details

Authors
  • Rollmann, BrunoUCLouvain
    Author
  • Van Der Auwera, P
    Author
  • Tulkens, Paul M.UCLouvain
    Author
Abstract
An immunoassay based on fluorescence polarization detection (FPIA) has been recently adapted for dibekacin. This has been compared with a reference method (high-performance liquid chromatography), and two other methods used in clinical laboratories for monitoring this aminoglycoside, namely substrate-labelled fluorescent immunoassay (SLFIA) and radioimmunoassay (RIA). FPIA was fast and more reliable than SLFIA or RIA, and offered therefore superior performance. However, its nominal cost per assay is high.
Affiliations

Citations

Rollmann, B., Van Der Auwera, P., & Tulkens, P. M. (1986). Dibekacin assay in serum by automated fluorescence polarization immunoassay (Abbott Tdx): Comparison with high-performance liquid chromatography, substrate-labelled fluorescent immunoassay and radioimmunoassay. Journal of Pharmaceutical and Biomedical Analysis, 4(1), 53-61. https://doi.org/10.1016/0731-7085(86)80023-1 (Original work published 1986)